Bioengineering Bacterially Derived Immunomodulants: A Therapeutic Approach to Inflammatory Bowel Disease.
Bioengineering Bacterially Derived Immunomodulants: A Therapeutic Approach to Inflammatory Bowel Disease.
复制标题
DOI:
10.1021/acsnano.7b03239
复制
发表时间:
2017-10-24
期刊:
影响因子:
17.1
通讯作者:
Neish AS
中科院分区:
文献类型:
--
作者:
Herrera Estrada L;Wu H;Ling K;Zhang G;Sumagin R;Parkos CA;Jones RM;Champion JA;Neish AS
Bacterial enteric pathogens have evolved efficient mechanisms to suppress mammalian inflammatory and immunoregulatory pathways. By exploiting the evolutionary relationship between the gut and pathogenic bacteria, we have developed a potential mucosal therapeutic. Our findings suggest that engineered preparations of the Salmonella acetyltransferase, AvrA, suppress acute inflammatory responses such as those observed in inflammatory bowel disease (IBD). We created 125 nm diameter cross-linked protein nanoparticles directly from AvrA and carrier protein to deliver AvrA in the absence of Salmonella. AvrA nanoparticles are internalized in vitro and in vivo into barrier epithelial and lamina propria monocytic cells. AvrA nanoparticles inhibit inflammatory signaling and confer cytoprotection in vitro, and in murine colitis models, we observe decreased clinical and histological indices of inflammation. Thus, we have combined naturally evolved immunomodulatory proteins with modern bioengineering to produce AvrA nanoparticles, a potential treatment for IBD.
登录
查看更多内容
影响因子:
16.1
作者:
Lai, Samuel K.;Wang, Ying-Ying;Hanes, Justin
通讯作者:
Hanes, Justin
影响因子:
8
作者:
通讯作者:
--
影响因子:
10.8
作者:
Jin, Tuo;Zhu, Hahao;Zhu, Hua
通讯作者:
Zhu, Hua
影响因子:
10.8
作者:
Cheng, Ru;Feng, Fang;Zhong, Zhiyuan
通讯作者:
Zhong, Zhiyuan
影响因子:
30.3
作者:
Galan, Jorge E.
通讯作者:
Galan, Jorge E.